Home >
Medicine Info >
Urifast 25 MG Suspension
Loading interface...

Urifast 25 MG Suspension

Manufactured byCipla Ltd.
ContainsNitrofurantoin
Description
Urifast 25 MG Suspension is a bactericidal antibiotic which is used to treat or prevent urinary tract infections. It should be used with caution in patients with kidney disease.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Urifast 25 MG Suspension

Niftran 25 ml Suspension
Ranbaxy Laboratories Ltd.

Side effects

Major & minor side effects for Urifast 25 MG Suspension

  • changes in facial skin color
  • Skin rash
  • Fever and chills
  • Burning or tingling sensation
  • Headache
  • Drowsiness
  • Diarrhea
  • Excessive gas in stomach

Uses of Urifast 25 MG Suspension

What is it prescribed for?

  • Urinary Tract Infection
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to Nitrofurantoin or any other inactive ingredients present in the formulation.

Impaired Kidney function

This medicine is not recommended for the patients who have improper kidney function with CrCl less than 60 ml/min.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. The risks and benefits should be discussed with the doctor before using this medicine.
General warnings

Lung diseases

This medicine should be used with caution in patients with lung diseases due to the increased risk of severe adverse effects. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Impaired liver function

This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Hemolytic anemia

This medicine may cause abnormal breakdown of blood cells. Close monitoring of blood cell count and hemoglobin is necessary. Discontinue the treatment if any signs of decreased hemoglobin and red blood cell count appear.

Drug-resistance

This medicine without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of developing bacteria that is drug-resistant.

Driving or operating machinery

This medicine may cause dizziness or drowsiness in some patients. It is advised that you do not perform any activities that require high mental alertness like driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take/Administer the missed dose as soon as you remember. If it’s almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Ethinyl Estradiol

Cholera Vaccine

Atorvastatin

Adalimumab

Disease interactions

Peripheral Neuropathy

This medicine may cause nerve damage especially in elderly patients with kidney impairment and diabetes mellitus. Any symptoms of tingling or burning sensation should be reported to the doctor. Close monitoring of kidney function is necessary.

Liver Disease

This medicine should be used with caution in patients with liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Follow all the instructions given by the doctor and administer/take this medicine exactly as advised. Do not administer/take in larger or smaller amounts than prescribed. Seek emergency medical treatment in case of any severe side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

May cause sleepiness

How it works
It works by interfering with the bacterial wall synthesis and thus stops the growth of the bacteria.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Urinary anti-infectives

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2020 [cited 27 January 2020]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/009175s036lbl.pdf

Nitrofurantoin 25mg/5ml Oral Suspension - Patient Information Leaflet (PIL) - (emc) [Internet]. Medicines.org.uk. 2020 [cited 27 January 2020]. Available from:

https://www.medicines.org.uk/emc/product/7818/pil

Nitrofurantoin - DrugBank [Internet]. Drugbank.ca. 2019 [cited 20 November 2019]. Available from:

https://www.drugbank.ca/drugs/DB00698
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Jan 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.